Deepika Bahl
Public Health Foundation of India, India
Title: Screen and identify hypertriglyceridemia and hypertriglyceridemic waist phenotype among adolescents (12-15 years) of Delhi
Biography
Biography: Deepika Bahl
Abstract
Statement of the Problem & Aim: Overweight and obesity are associated with various co-morbidities. With this background, present study aims to screen and identify school going adolescents with hypertriglyceridemia and hypertriglyceridemic waist phenotype among adolescents of Delhi.
Method: Cross-sectional study was done with 877 adolescents (12-15 years) selected from four public schools of Delhi. Based on body mass index, waist circumference and waist to height ratio subjects were screened to identify high risk subjects. Of the screened subjects’ serum triglycerides was estimated to identify hypertriglyceridemia and hypertriglyceridemic waist phenotype.
Result: 33.2% of subjects were screened and their serum triglycerides was estimated. Hypertriglyceridemia among subject was 35.7% (males 32.9%, females 41.3%, p=0.4). Triglycerides were significantly associated with BMI (r=0.12, p=0.04); WC (r=0.19, p≤0.001) and body weight (r=0.10, p=0.03). Waist circumference (≥90 percentile) had higher odds for having an elevated serum triglyceride concentration (OR=2.08, 95% CI=1.19-3.63) in comparison to waist circumference <90 percentile. Prevalence of hypertriglycemic waist phenotype among screened subject was 26.20% (males 25.6%, females 27.1%, p=0.06). Higher prevalence of hypertriglycemic waist phenotype was seen in obese subject in comparison to overweight subjects (p=0.002). Similarly, higher prevalence hypertriglycemic waist phenotype was seen in subject with waist to height ratio greater than 0.5 in comparison to waist to height ratio less than 0.5 (p=0.00).
Conclusion: High prevalence of hypertriglyceridemia and hypertriglyceridemic waist phenotype among adolescents indicates need of proactive preventive measures with focus on diet and physical activity to avoid future non-communicable disease epidemic and related co-morbidities.